TABLE 2.
Alcohol and Drug Use Among STI Clinic Patients Who HIV Seroconverted and Patients Who Remained HIV-Negative At Follow-Up: Cape Town, South Africa, 2006–2008
| Seroconverters (n = 29), No. (%) | Remained HIV-Negative (n = 77), No. (%) | OR (95% CI) | |
| Previous month alcohol use | |||
| Baseline | 10 (35) | 36 (47) | |
| 12-month follow-up | 4 (14) | 33 (43) | 4.9* (1.4, 17.5) |
| Problem drinkinga | |||
| Baseline | 11 (38) | 30 (39) | |
| 12-month follow-up | 3 (11) | 12 (16) | 2.6 (0.5, 13.6) |
| Alcohol use before sexual intercourse | |||
| Baseline | 10 (35) | 29 (38) | |
| 12-month follow-up | 3 (10) | 19 (25) | 2.9 (0.7, 11.2) |
| Previous month other drug use | |||
| Baseline | 4 (14) | 13 (7) | |
| 12-month follow-up | 1 (4) | 11 (15) | 4.8 (0.69, 41.4) |
| Drug use before sexual intercourse | |||
| Baseline | 4 (14) | 5 (6) | |
| 12-month follow-up | 1 (3) | 4 (5) | 2.2 (0.2, 24.2) |
Notes. CI = confidence interval; OR = odds ratio; STI = sexually transmitted infection.
Assessed by lcohol Use Disorder Identification Test. a 10-item self-report instrument that includes quantity and frequency of alcohol use and was designed to identify individuals for whom the use of alcohol places them at risk for developing alcohol-related problems or who are currently experiencing alcohol-related problems.12
P < .01.